首页|柚皮苷对小鼠高脂血症的作用研究

柚皮苷对小鼠高脂血症的作用研究

扫码查看
目的 探讨柚皮苷对小鼠高脂血症的影响,并阐明其作用机制.方法 将C57BL/6小鼠随机分为对照组、高血脂组和柚皮苷组.高血脂组和柚皮苷组小鼠饲喂高脂饲料,持续喂养4周,建立小鼠高脂血症模型.对照组小鼠饲喂正常饲料.造模成功后,柚皮苷组小鼠每日灌胃200 mg·kg-1柚皮苷,对照组和高血脂组小鼠均灌胃等量0.9%NaCl,连续灌胃5周.收集小鼠血液进行血脂检测.收集小鼠肝组织,用生化法检测超氧化物歧化酶(SOD)、过氧化氢酶(CAT)活性和丙二醛(MDA)、谷胱甘肽(GSH)含量,用蛋白质印迹法检测目的蛋白的表达水平.结果 对照组、高血脂组和柚皮苷组小鼠肝组织中SOD活性分别为(58.43±6.27)、(37.16±4.10)和(51.23±4.81)U·mg prot-1,CAT 活性分别为(176.11±13.59)、(112.65±10.02)和(158.46±14.37)U·mg prot-1,MDA含量分别为(3.15±0.74)、(12.62±2.07)和(5.76±1.83)U·mg prot-1,GSH含量分别为(91.52±11.47)、(34.16±4.62)和(71.64±8.79)U·mg prot-1,诱导型一氧化氮合酶(iNOS)蛋白相对表达水平分别为0.28±0.05、4.26±1.13和0.94±0.19,腺苷酸活化蛋白激酶(AMPK)蛋白相对表达水平分别为1.32±0.18、0.84±0.11和1.49±0.16,胆固醇调节元件结合蛋白(SREBP)蛋白相对表达水平分别为1.76±0.24、5.78±1.21和2.93±0.42,3-羟基3-甲基戊二酰辅酶A还原酶(HMGCR)蛋白相对表达水平分别为1.69±0.18、6.13±1.38和3.26±0.43.对照组和柚皮苷组的上述指标与高血脂组比较,在统计学上差异均有统计学意义(P<0.05,P<0.01,P<0.001).结论 柚皮苷能够有效调节高脂血症小鼠的血脂水平,抑制氧化应激反应和细胞凋亡水平,其作用机制可能与调控AMPK/HMGCR/SREBP信号通路有关.
Effects of naringin on hyperlipidemia in mice
Objective To investigate the effect of naringin on hyperlipidemia in mice and to elucidate its mechanism.Methods C57BL/6 mice were randomly divided into control group,hyperlipidemia group and naringin group.Mice in hyperlipidemia group and naringin group were fed high-fat diet for 4 weeks,and hyperlipidemia model was established.The control group was fed normal diet.After successful modeling,naringin group mice were intragastric with 200 mg·kg-1 naringin per day,and mice in control group and hyperlipemia group were intragastric with 0.9%NaCl per day for 5 weeks.The blood of mice was collected for lipid detection.The activities of superoxide dismutase(SOD)and catalase(CAT)and the contents of malondialdehyde(MDA)and glutathione(GSH)were detected by biochemical method.Western blot was used to detect the protein expression.Results The activity of SOD in liver tissue of mice in control group,hyperlipidemia group and naringin group were(58.43±6.27),(37.16±4.10)and(51.23±4.81)U·mg prot-1,respectively;CAT activities were(176.11±13.59),(112.65±10.02)and(158.46±14.37)U·mg prot-1,respectively;the contents of MDA were(3.15±0.74),(12.62±2.07)and(5.76±1.83)U·mg prot-1;the contents of GSH were(91.52±11.47),(34.16±4.62)and(71.64±8.79)U·mg prot-1,respectively;the relative protein expression levels of induced nitric oxide synthase(iNOS)were 0.28±0.05,4.26±1.13 and 0.94±0.19;the relative protein expression levels of adenosine 5'-monophosphate activated protein kinase(AMPK)were 1.32±0.18,0.84±0.11 and 1.49±0.16,respectively;the relative protein expression levels of cholesterol regulatory element binding protein(SREBP)were 1.76±0.24,5.78±1.21 and 2.93±0.42;the relative protein expression levels of 3-hydroxy-3-methyl glutaryl coenzyme A reductase(HMGCR)were 1.69±0.18,6.13±1.38 and 3.26±0.43,respectively.The above indexes in the control group and the naringin group were significantly different from those in the hyperlipidemia group(P<0.05,P<0.01,P<0.001).Conclusion Naringin can effectively regulate the level of blood lipids,inhibit oxidative stress and apoptosis in hyperlipidemia mice,and its mechanism may be related to the regulation of AMPK/HMGCR/SREBP signaling pathway.

naringinadenosine 5'-monophosphate activated protein kinase/3-hydroxy-3-methyl glutaryl coenzyme A reductase/sterol-regulatory element binding proteins signaling pathwayhyperlipidemiaoxidative stress

姜海斌、蒋锐、杨丽洁

展开 >

常德职业技术学院内科教研室,湖南常德 415000

常德职业技术学院诊断教研室,湖南常德 415000

柚皮苷 腺苷酸活化蛋白激酶/3-羟基3-甲基戊二酰辅酶A还原酶/胆固醇调节元件结合蛋白信号通路 高脂血症 氧化应激

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(19)